![]() PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. | ![]() Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | ||
Founding Date | Founding Date N/A | Founding Date 2004 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Rapperswil-Jona, CH HQ | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations Seattle, US HQ |
Employees | Employees 1 | Employees 49 | Employees 1182% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 52.8 m | Valuation ($) 4.1 m |
Financial | |||
Net income | Net income N/A | Net income (€23.5m) (FY, 2023) | Net income ($26m) (FY, 2025) |

PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors.
View company
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company